Epigral Limited — Credit Ratings, 07-03-2025: Credit Rating- Revision
CRISIL Ratings has upgraded the long-term rating of Epigral Limited to CRISIL AA/Stable from CRISIL AA-/Positive and reaffirmed its short-term rating at CRISIL A1+ for its bank facilities totaling ₹1,050 crore. This upgrade reflects the company's improved financial health, evidenced by stable revenue streams and effective debt management.
The escalation in the rating indicates a positive outlook driven by robust operational performance and prudent financial strategies. Factors contributing to the rating action include the company's manageable debt levels and consistent revenue stability, which bolster investor confidence.
This rating upgrade is significant as it may lead to reduced borrowing costs for Epigral Limited, enhancing their capacity to invest strategically and expand operations. The improved perception in the credit market could attract more favorable investment opportunities, leveraging the positive sentiment for future growth.
Overall, this rating action positions Epigral favorably for capital raising while signaling strong operational fundamentals that could resonate well with investors looking for stability in an evolving market landscape.
